NightHawk Biosciences Profit Margin

The latest profit margin for NHWK is -704.47% as of September 2025. That compares with -1128.75% in the prior-year period — up 37.6% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside NightHawk Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, NHWK's profit margin moved from -1128.75% to -704.47% — a 37.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NightHawk Biosciences's valuation or profitability profile.

Against Healthcare companies, NHWK currently prints -704.47% for profit margin, while the sector average sits near 13.89%. That is roughly 5170.6% below the sector mean. Large gaps often invite a closer look at NightHawk Biosciences's growth, margins, and balance sheet.

Profit Margin shows how effectively NightHawk Biosciences converts resources into returns. At -704.47%, NHWK may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1128.75% in the prior-year period — up 37.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting NHWK's profit margin (-704.47%), review year-over-year change from -1128.75%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.